Skip to main content
GutCited

Psyllium Husk per Irritable Bowel Syndrome (IBS)

B

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dpsyllium\u002Dhusk\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

Key Study Findings

Observational Study n=97
Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and …
Dose: None vs: None Outcome: IBS management heterogeneity in Latin America Effetto: None None

Popolazione: Latin American gastroenterologists (DGBI specialists)

Review
The role of dietary fiber in the gastrointestinal tract: when, how and why?
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Review of dietary fiber role in GI tract

Randomized Controlled Trial 3 weeks Double-blind
Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review …
Dose: None vs: Placebo Outcome: Pain outcomes Effetto: None None

Popolazione: IBS patients

Review
The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention …
Dose: None vs: None Outcome: Colitis severity Effetto: None None

Popolazione: Ulcerative colitis patients

Systematic Review
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Dose: Peppermint oil, STW-5, psyllium, others vs: Standard care or placebo Outcome: Symptom improvement in GI diseases Effetto: None None

Popolazione: Patients with gastroenterological diseases

Randomized Controlled Trial n=314
Sex-Dependent Efficacy of Dietary Fiber in Pediatric Functional Abdominal Pain.
Dose: Dietary fiber (psyllium) vs: Low fiber diet Outcome: Abdominal pain frequency Effetto: None None

Popolazione: Children with functional abdominal pain disorders

Key Statistics

8

Studi

900

Partecipanti

Positive

B

Grado

Referenced Papers

The Medical letter … 2025
The Medical letter … 2020
International journal of … 2017 146 citazioni
Journal of gastroenterology … 2017 32 citazioni
Current opinion in … 2017 24 citazioni
International journal of … 2016 69 citazioni
Clinical gastroenterology and … 2016 2 citazioni
Digestion 2014 61 citazioni
The American journal … 2013 421 citazioni
Journal of clinical … 2011 30 citazioni
Alimentary pharmacology & … 2011 3 citazioni
Current opinion in … 2010 22 citazioni
Australian family physician 2009 12 citazioni
International journal of … 2007 375 citazioni
Current treatment options … 2006 24 citazioni
Biomedicine & pharmacotherapy … 1986 4 citazioni
Annals of internal … 1981 6 citazioni
JAMA 1964

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
5-10 g/day (with adequate water)
ibssupport:
5-10 g/day (start low, titrate up over 1-2 weeks)
constipation:
10-20 g/day in divided doses with at least 240 mL water per dose

Limite massimo: Well-tolerated up to 30 g/day with adequate fluid intake

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Mixed 97
None -- Mixed --
None 3 weeks Positive --
None -- Positive --
Peppermint oil, STW-5, psyllium, others -- Positive --
Dietary fiber (psyllium) -- Positive 314
2 g -- Mixed --
Low-FODMAP, probiotics, fiber -- Positive --

Momento migliore per l'assunzione: With meals and a full glass of water (240 mL minimum); space 1-2 hours from medications

Safety & Side Effects

Effetti collaterali segnalati

  • Gas and bloating (common initially; start with low dose and titrate up)
  • Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water)
  • Abdominal cramping at high initial doses
  • May reduce appetite (feeling of fullness)

Interazioni note

  • May reduce absorption of medications if taken simultaneously (space 1-2 hours)
  • Lithium (reduced absorption)
  • Carbamazepine (reduced absorption)
  • Diabetes medications (may enhance blood sugar lowering; monitor glucose)

Livello di assunzione massimo tollerabile: Well-tolerated up to 30 g/day with adequate fluid intake

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Psyllium Husk help with Irritable Bowel Syndrome (IBS)?
Based on 8 studies with 900 participants, there is moderate evidence from clinical studies that Psyllium Husk may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Psyllium Husk should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 5-10 g/day (with adequate water). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Psyllium Husk?
Reported side effects may include Gas and bloating (common initially; start with low dose and titrate up), Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water), Abdominal cramping at high initial doses, May reduce appetite (feeling of fullness). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Psyllium Husk and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 8 peer-reviewed studies with 900 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.